(Reuters) -Morgan Stanley backed its bullish stance on U.S. equities on Monday, citing strong earnings momentum, and said it ...

Sarepta stock tanked Friday after a new patient death was uncovered, spurring an FDA request to halt shipments of an ...

Investing.com -- Jefferies initiated coverage of Jefferson Capital Inc with a Buy rating and a $29 price target, pointing to the company’s differentiated tech-based model, consistent financial ...

The Mirror's Mark Jefferies gives his take on Oasis' triumphant reunion in Manchester as the Wonderwall stars head to Wembley ...

Comedian Jim Jefferies unleashes his thoughts on tiny moustaches, straight-guy struggles and why acting doesn't count as a ...

The US-based company's latest funding round has been led by private equity giant L Catterton - which itself is backed by ...

As the controversy over the safety of Sarepta Therapeutics’ gene therapies comes to a head, the biotech is standing firm ...

Jefferies raises S&P 500 2025 year-end target to 5,600. Explore sector strategies, economic trends & stock valuation insights.

Starbucks Corporation (NASDAQ:SBUX) is a stock that Jim Cramer frequently discusses on his morning show. The CNBC TV host is ...

South Korean fashion retailer F&F Co said on Monday it has hired Goldman Sachs to advise on an acquisition of TaylorMade, and ...

A teen is charged with murder after he shot and killed another teen at a watermelon festival in South Carolina, according to ...

Late Saturday, investigators working the murder of a 17-year-old boy at the Pageland Watermelon Festival arrested another ...